Targeting the Par-4 Protein as a Novel Approach in Depression Treatment

Summary Harvard researchers have discovered methods for identifying agents that modulate the interaction between Par-4 and the dopamine D2 receptor (D2DR). The ability to screen for this interaction may provide researchers with the ability to identify specific small molecule inhibitors of this interaction, providing a novel class of depression therapeutics.

Applications A target for the development of treatments for depression. For Further Information Please Contact the Director of Business Development Michal Preminger Email: [email protected] Telephone: (617) 432-0920

Inventor(s): Tsai, Li-Huei

Type of Offer: Licensing



« More Pharmaceutical Patents

---